Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hübschmann

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
Scientific Reports|May 12, 2018
Genomic features of renal cell carcinoma with venous tumor thrombusGregor Warsow, Daniel Hübschmann, Kortine Kleinheinz, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Nature Communications|June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityRouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
Cancer Medicine|December 2, 2024
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic CancerFederico Nichetti, Marco Silvestri, Luca Agnelli, et al.
Science Advances|September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggabilityManuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Acta Neuropathologica|May 6, 2017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signatureFelix Sahm, Umut H Toprak, Daniel Hübschmann, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
NPJ Precision Oncology|January 10, 2025
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina A Kerle, Thomas Gross, Anja Kögler, et al.
Scientific Reports|May 12, 2018
Genomic features of renal cell carcinoma with venous tumor thrombusGregor Warsow, Daniel Hübschmann, Kortine Kleinheinz, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Nature Communications|June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneityRouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
Cancer Medicine|December 2, 2024
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic CancerFederico Nichetti, Marco Silvestri, Luca Agnelli, et al.
Science Advances|September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggabilityManuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Acta Neuropathologica|May 6, 2017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signatureFelix Sahm, Umut H Toprak, Daniel Hübschmann, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
Pageof 10